CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-01 | Stern Aron Chief Administrative Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-06-09 | Nash Duane President | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2018-06-09 | Henry Andrew VP, Clinical Operations | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-06-09 | Ashley Robert A. Chief Technical Officer, EVP | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-06-09 | Swanson Michael V. Chief Financial Officer, EVP | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-06-09 | MURAWSKI RICHARD M Vice President, Manufacturing | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2018-06-09 | DUNN JOHN MICHAEL General Counsel and Secretary | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2018-05-23 | Halperin Errol R. Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | Hasnain Faheem Director | Grant or award · Stock Option (right to buy) | +41,353 | 41,353 | ||
| 2018-05-23 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | BIENAIME JEAN JACQUES Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | Millis J. Michael Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | Godshall Douglas Evan Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | SEARS LOWELL Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-05-23 | Satter Muneer A Director | Grant or award · Stock Option (right to buy) | +29,538 | 29,538 | ||
| 2018-01-03 | Cox Russell J. Chief Executive Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +1,588,832 | 1,588,832 | ||
| 2017-12-13 | Satter Muneer A Director | Purchase | +50,000 | $5.57 | $279K | 11,382,277 |
| 2017-12-12 | Satter Muneer A Director | Purchase | +50,000 | $5.40 | $270K | 11,332,277 |
| 2017-12-11 | Satter Muneer A Director | Purchase | +50,000 | $4.96 | $248K | 11,282,277 |
| 2017-12-08 | Satter Muneer A Director | Purchase | +50,000 | $4.92 | $246K | 11,232,277 |
Page 14 of 16 · 311 trades